Search for: "R. J. Johnson"
Results 41 - 60
of 1,835
Sorted by Relevance
|
Sort by Date
7 Aug 2014, 11:48 am
J&J is not even calling this a recall. [read post]
15 Jul 2016, 7:48 am
Now, Johnson & Johnson has fired back on those claims,with a spokeswoman telling Legal Newsline that the decision to sue the company was not just, and that the company has no plans to settle the case. [read post]
25 Jan 2010, 8:42 pm
The United States filed a qui tam or False Claims Act complaint against Johnson & Johnson (J&J) and its subsidiary companies Johnson & Johnson Health Care Systems Inc. and Ortho-McNeil-Janssen Pharmaceuticals Inc. [read post]
6 Jun 2012, 7:41 pm
Johnson & Johnson Unit to Halt Urinary Implants, New York Times, June 5, 2012 J & J will phase out women's pelvic mesh linked to personal injury lawsuits, The Washington Post, June 5, 2012 More Blog Posts: Another Transvaginal Mesh Lawsuit Filed Against Johnson & Johnson Over Serious Side Effects, Boston Injury Lawyer Blog, May 17, 2012 Boston Products Liability? [read post]
12 Sep 2012, 6:08 pm
California -- Johnson & Johnson unit Janssen Pharmaceuticals Inc. was vindicated Tuesday in its efforts to prevent Lupin Pharmaceuticals Inc. from making and marketing a generic version of J&J's popular birth control drug Ortho Tri-Cyclen Lo, as a New Jersey federal judge ruled that the underlying patent is valid. [read post]
3 Feb 2016, 10:50 am
According to a recent Bloomberg news article, Johnson & Johnson (J&J) has begun to settle thousands of personal injury and product liability lawsuits filed by women who blame the company’s vaginal-mesh inserts for causing severe injuries. [read post]
28 Feb 2014, 3:02 pm
District Judge Joseph R. [read post]
7 Jan 2015, 6:39 am
The patenting activities of Johnson & Johnson are definitely robust. [read post]
11 Apr 2013, 12:32 pm
A South Dakota woman, who had sued Johnson & Johnson after experiencing complications with a vaginal mesh implant, was awarded $3.35 million after a jury determined J&J and its subsidiary Ethicon Inc., failed to adequately warn her doctor of potential dangers of the implant and misrepresented the product in its brochures. [read post]
19 Oct 2015, 6:07 am
A ten juror panel in New Jersey found for Johnson & Johnson (J&J) on all counts on Friday. [read post]
4 Oct 2010, 9:48 am
Bloomberg News reports, “Johnson & Johnson should pay $351 million to Louisiana for defrauding the state’s Medicaid system with false claims about the safety of its antipsychotic drug Risperdal [risperidone], a lawyer for the state told jurors. [read post]
7 May 2011, 1:25 pm
Did DePuy Orthopaedics, subsidiary of New Jersey-based Johnson & Johnson, knowingly sell defective hip implant devices? [read post]
19 Dec 2018, 9:27 am
A recently-released Reuters report indicates that Johnson & Johnson (J&J) knew about the hidden dangers in its talc products for decades. [read post]
1 May 2014, 8:13 am
Johnson and Johnson Hurts Women, is blasting the manufacturer for lies that have resulted in serious injuries and harm caused by transvaginal mesh products. [read post]
10 Mar 2013, 2:18 pm
This year is not turning out well for Johnson & Johnson. [read post]
12 Mar 2015, 8:55 am
Johnson and Johnson (J&J) the world’s largest pharmaceutical and medical device maker is hammered in another loss in the on going transvaginal mesh wars. [read post]
25 Feb 2014, 7:00 am
District Judge Joseph Goodwin in Charleston, West Virginia…granted a directed verdict for J&J on Carolyn Lewis’s claims that a TVT Retropubic sling implanted to treat incontinence was improperly designed, Matthew Johnson, a spokesman for J&J’s Ethicon unit,” the maker of the sling, “said in an e-mail. [read post]
17 Nov 2020, 2:17 pm
Republished by Blog Post PromoterJohnson & Johnson started it. [read post]
5 Dec 2016, 11:07 am
Johnson & Johnson Appeals the Verdict Following the verdict, Johnson & Johnson and DePuy announced that they will appeal the decision, denying any wrongdoing. [read post]
15 Jul 2012, 7:00 pm
Johnson & Johnson revealed last week that it intends on providing more corporate oversight of its drug manufacturing and marketing practices. [read post]
